Cargando…

2721. Respiratory Virus Infections Following CAR T-cell Therapy: Risk Factors and Outcomes

BACKGROUND: Chimeric antigen receptor (CAR) T-cell therapy is a novel cancer therapy which functions by engineering patients’ own cells to target a malignancy. The preparative lymphodepleting chemotherapy and cell versus tumor effect create a novel, dynamic state of immunocompromise. Respiratory vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Powell, Natasha, Pisano, Jennifer, Czapka, Michael T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677858/ http://dx.doi.org/10.1093/ofid/ofad500.2332

Ejemplares similares

83. Infectious Outcomes of CAR T-cell Therapy: Longitudinal Follow Up and Risk Stratification
por: Czapka, Michael, et al.
Publicado: (2022)

2721. US States’ Policies for Meningococcal Vaccination vs. Disease Epidemiology
por: Srivastava, Amit, et al.
Publicado: (2019)

A more general role for WR-2721 in cancer therapy.
por: Yuhas, J. M.
Publicado: (1980)

Radiosensitisation and radioprotection by BSO and WR-2721: the role of oxygenation.
por: Durand, R. E., et al.
Publicado: (1989)

Antiretroviral activity of aminothiols, WR2721 and WR1065
por: Poirier, Miriam C, et al.
Publicado: (2006)

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
por: Twentyman, P. R.
Publicado: (1981)

Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
por: Rojas, A., et al.
Publicado: (1983)

Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.
por: Rojas, A., et al.
Publicado: (1982)

Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.
por: Yuhas, J. M., et al.
Publicado: (1980)

Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
por: Twentyman, P. R.
Publicado: (1983)

1994. Infections following Chimeric Antigen Receptor (CAR) – T cell Therapy: 2018-2022
por: Keri, Vishakh C, et al.
Publicado: (2023)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
por: McNally, N. J.
Publicado: (1982)

Radioprotection by WR-2721 in vitro at low oxygen tensions: implications for its mechanisms of action.
por: Durand, R. E.
Publicado: (1983)

Proceedings: Radioprotective effect of WR 2721 in combined injured mice (x-irradiation and skin lesion).
por: Verspohl, F., et al.
Publicado: (1975)

Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation
por: Molkentine, Jessica M., et al.
Publicado: (2019)

1182. Clinical Outcomes of Hospital-Associated Respiratory Virus Infections
por: Petrie, Joshua G, et al.
Publicado: (2019)

1599. Rejection Outcomes in Lung Transplant Recipients Post Respiratory Syncytial Virus Infections
por: Permpalung, Nitipong, et al.
Publicado: (2018)

2506. Reactivation of Latent Cytomegalovirus Infection Following Major Surgery: Risk Factors and Outcomes
por: Herrick, Katherine, et al.
Publicado: (2018)

1549. Impact of New Fluoroquinolone Breakpoints on Enterobacteriaceae Susceptibility Rates and Clinical Outcomes
por: Pettit, Natasha N, et al.
Publicado: (2019)

925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy
por: Trottier, Caitlin, et al.
Publicado: (2021)

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects
por: Hospers, G A P, et al.
Publicado: (1999)

2611. Risk Factors Associated with Longer Hospital Stay in Adult Patients with Respiratory Syncytial Virus Infections
por: Bhargava, Ashish, et al.
Publicado: (2023)

636. Epidemiology and Outcome Among the Elderly Hospitalized Patients with Respiratory Syncytial Virus Infections
por: Bhargava, Ashish, et al.
Publicado: (2023)

1105. The Burden of Infections Prior to Chimeric Antigen Receptor (CAR) Modified T-cell Therapy Predicts Post-CAR T-cell Infectious Complications
por: Garner, Will, et al.
Publicado: (2020)

578. Infections in Patients Treated with Chimeric Antigen Receptor T-cells (CAR-T) therapy
por: Tran, Nikki, et al.
Publicado: (2020)

Beneficial effect of the oxygen free radical scavenger amifostine (WR-2721) on spinal cord ischemia/reperfusion injury in rabbits
por: Chronidou, Fany, et al.
Publicado: (2009)

Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage
por: Liu, Wei, et al.
Publicado: (2015)

2717. Beware the bacteria: risk of bacterial infections persists more than 60 days post CAR-T
por: Mathur, Poonam, et al.
Publicado: (2023)

Acute psychosis following corticosteroid administration for COVID-19 and Respiratory Syncytial Virus infection: A case study
por: Miranda Ruiz, E., et al.
Publicado: (2023)

447. Clinical Features, Risk Factors, and Outcomes of COVID-19 in Immunocompromised Adults Hospitalized with Acute Respiratory Infection
por: Taylor, Elizabeth G, et al.
Publicado: (2023)

2644. Presence of Respiratory Viruses in the Upper Respiratory Tract of Febrile Infants ≤90 Days Old is Associated with Lower Prevalence of Invasive Bacterial Infection
por: Nicholson, Erin G, et al.
Publicado: (2023)

2448. Clinical Presentation and Outcomes of Long-Term Care Residents with Coronavirus Respiratory Infection: A Retrospective Cohort Study
por: Williams, Victoria R, et al.
Publicado: (2019)

1055. Addition of Antimicrobial Stewardship Program Weekend Coverage Increases Interventions while Reducing Antimicrobial Duration and Cost
por: Pettit, Natasha N, et al.
Publicado: (2019)

Amifostine (WR-2721) Mitigates Cognitive Injury Induced by Heavy Ion Radiation in Male Mice and Alters Behavior and Brain Connectivity
por: Boutros, Sydney Weber, et al.
Publicado: (2021)

1039. Forty-eight-hour Antibiotic Time-out: Impact on Antibiotic Duration and Clinical Outcomes
por: Pettit, Natasha N, et al.
Publicado: (2019)

118. Nasopharyngeal (NP) Bacterial Detection in Infants With Respiratory Syncytial Virus (RSV) Infection: Impact on Clinical Outcomes
por: Diaz, Alejandro, et al.
Publicado: (2018)

1550. Pediatric Febrile Neutropenia: Does Depth and Duration of Neutropenia at Presentation Predict Outcomes?
por: Alali, Muayad, et al.
Publicado: (2018)

The prevention of respiratory syncytial virus infection
por: Bollani, L, et al.
Publicado: (2014)

WHO Severe Acute Respiratory Infections (SARI) Definition often Underdiagnoses Serious Respiratory Viral Infections in Hospitalized Jordanian Children
por: Khuri-Bulos, Najwa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hqaihljib218dg3heinf0bl9q1